Check4Cancer

Are you looking for skin cancer app and take high quality images at home? GIANT Health is proud to announce our exhibitor and sponsor Check4Cancer at GIANT Health #GIANT2024 Check4Cancer (C4C) is an award-winning early cancer detection company that provides tech-enabled solutions for cancer risk assessment, prevention, screening & diagnostics to insured, corporate & self-pay markets in UK. Check4Cancer is delighted to have the opportunity to demonstrate the functionality and novelty of the recently developed AI model for skin cancer detection, as well as thier skin cancer app that can take high quality images at home. 📅9-10 December 2024, London Register now and connect, share ideas, and inspire innovation together: 🎟️https://bit.ly/3ZEop3D #healthcare #innovation #event #HealthTech #DigitalHealth

This Mercer–Health report highlights the fact that prevention and early detection are proven strategies for transforming cancer outcomes for employees and indeed the UK in general. This mission lies at the heart of everything we do - driving impactful change with proactive solutions, for individuals and employers.

Really looking forward to this event! 👇 Hope to see you there 😃

Yesterday, we hosted a fantastic working breakfast event at The Folly in London, bringing together many of the brokers we proudly work with. The event kicked off with a networking session and breakfast, creating a great opportunity to connect and share insights. This was followed by an informative presentation hosted by Professor Gordon Wishart and Louise Mills, covering: - Stats and figures on cancer incidence and screenings - The innovative solutions Check4Cancer offers - Real-life stories about our patients' experience The session highlighted the critical role Check4Cancer plays in employee benefits, helping brokers understand how prevention and early diagnosis can transform lives and businesses alike. A big THANK YOU to everyone who attended—together, we’re making strides towards better cancer care and awareness. First image (L- R): Amy Bowers, Jenny Huby, Sue Fisher, Cerys Roach #EmployeeBenefits #CancerPrevention #EarlyDiagnosis #Check4Cancer

What a great time we had at the amii Association of Medical Insurers and Intermediaries Health & Wellbeing Summit yesterday. Thank-you to those who organised it so well. Our very own Professor Gordon Wishart delivered a fascinating and thought-provoking talk on the challenges facing cancer provision in the UK and how we can navigate our way out of it. The key takeaway? Prevention and early diagnosis is EVERYTHING. It was also a pleasure to have our new Head of Commercial Partnerships, Julia Suckling, with us at the event. Exciting times are ahead as we work together to drive innovation and expand our partnerships to reach as many people as possible with preventative education and the checks they need to minimise the effects of cancer. Here’s Gordon and Julia at the event — both dedicated to making a difference in cancer care. #CancerPrevention #EarlyDiagnosis #HealthcareInnovation #AMII2024 #Check4Cancer

Gordon Wishart takes to the stage and a packed auditorium at amii Association of Medical Insurers and Intermediaries Autumn event in London today, to discuss the challenges in cancer provision in the UK.

🙌 We’ll be at the amii (amii Association of Medical Insurers and Intermediaries), tomorrow. Gordon Wishart will be speaking at the event about ‘The current challenges with cancer provision and navigating your way out of the perfect storm.’ - a topic that will be of interest to anyone who provides any sort of cancer care service. Do also stop by the Check4Cancer stand if you’re going. We’d be delighted to see you and to tell you about our offering 😊

On stage now at MedTech Malta 2024: NHS Unplugged: Rewiring Healthcare in the UK We're thrilled to have Prof. Gordon Wishart, Founder, CEO & Chief Medical Officer at Check4Cancer, sharing his vision on how innovative cancer screening and early diagnosis can transform patient outcomes and advance the future of healthcare. Joining him are distinguished panelists Michael Bell, Chair of NHS South West London Integrated Care System and Lewisham and Greenwich NHS Trust; Jobin Jose, Co-Founder of HealthOrbit AI; and Dr. Tom Micklewright, Medical Director at ORCHA. The session is moderated by Dr. Gege GATT, CEO of EBO.ai. An inspiring exchange on digital health's potential to reshape the NHS and improve access to critical services across the #UK! See the event in photos with our LIVE coverage here: https://lnkd.in/dRpMH8tm ✨Supported by: Lifeblood, Malta Enterprise, VisitMalta Incentives & Meetings, Malta Digital Innovation Authority, Ministry for Health and Active Ageing, Government of Malta

Live from MedTech World Malta - Check4Cancer’s CEO & MD, Professor Gordon Wishart, CCO & CFO, Lorraine Lander and CTO, Jacob Cordran showcasing our AI-powered skin cancer detection app. Earlier today, Prof Wishart provided delegates with insights into how our app leverages cutting-edge AI and robust clinical data to transform skin cancer detection—bringing reliable, early assessment straight to users’ fingertips. It’s been an incredible opportunity to connect with healthcare innovators and explore partnerships that will help expand our mission globally. If you’re at MedTech World, please do visit our stand to see the app in action and learn more about our digital skin cancer pathway. #MedTechWorldMalta #Check4Cancer #AIforHealthcare #SkinCancerDetection #EarlyDetection #InnovationInHealthcare #GlobalHealthSolutions